Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study (Q24563021)

From Wikidata
Revision as of 20:12, 1 November 2023 by PangolinBot (talk | contribs) (‎Removed claim: author name string (P2093): Eva Hellstrom-Lindberg, Removed unnecessary author)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
scientific article

    Statements

    Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study (English)
    0 references
    Ghulam J Mufti
    Steven D Gore
    John F Seymour
    John M Bennett
    Linda Zimmerman
    David McKenzie
    March 2009
    0 references
    10
    0 references
    3
    0 references
    223-32
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit